Barry J. Oliver
Advertisement
Barry J. Oliver, vice president, Quality, Catalent Cell, Gene & Protein Therapies.
Articles by Barry J. Oliver
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI Milan Names 2026 Pharma Awards Finalists
2
AAPS PharmSci 360: CMC Strategies, Part 1
3
What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation
4
AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1
5